333 related articles for article (PubMed ID: 29023469)
21. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
Joshi I; Minter LM; Telfer J; Demarest RM; Capobianco AJ; Aster JC; Sicinski P; Fauq A; Golde TE; Osborne BA
Blood; 2009 Feb; 113(8):1689-98. PubMed ID: 19001083
[TBL] [Abstract][Full Text] [Related]
22. Notch dimerization is required for leukemogenesis and T-cell development.
Liu H; Chi AW; Arnett KL; Chiang MY; Xu L; Shestova O; Wang H; Li YM; Bhandoola A; Aster JC; Blacklow SC; Pear WS
Genes Dev; 2010 Nov; 24(21):2395-407. PubMed ID: 20935071
[TBL] [Abstract][Full Text] [Related]
23. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.
Gekas C; D'Altri T; Aligué R; González J; Espinosa L; Bigas A
Leukemia; 2016 Oct; 30(10):2002-2010. PubMed ID: 27125305
[TBL] [Abstract][Full Text] [Related]
24. Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation.
Aster JC; Bodnar N; Xu L; Karnell F; Milholland JM; Maillard I; Histen G; Nam Y; Blacklow SC; Pear WS
PLoS One; 2011; 6(10):e25645. PubMed ID: 22022427
[TBL] [Abstract][Full Text] [Related]
25. Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequency.
Blackburn JS; Liu S; Raiser DM; Martinez SA; Feng H; Meeker ND; Gentry J; Neuberg D; Look AT; Ramaswamy S; Bernards A; Trede NS; Langenau DM
Leukemia; 2012 Sep; 26(9):2069-78. PubMed ID: 22538478
[TBL] [Abstract][Full Text] [Related]
26. Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL.
Tottone L; Zhdanovskaya N; Carmona Pestaña Á; Zampieri M; Simeoni F; Lazzari S; Ruocco V; Pelullo M; Caiafa P; Felli MP; Checquolo S; Bellavia D; Talora C; Screpanti I; Palermo R
Front Oncol; 2019; 9():198. PubMed ID: 31001470
[TBL] [Abstract][Full Text] [Related]
27. Notch in Leukemia.
McCarter AC; Wang Q; Chiang M
Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836
[TBL] [Abstract][Full Text] [Related]
28. Distinct roles for Notch1 and Notch3 in human adipose-derived stem/stromal cell adipogenesis.
Liu MC; Logan H; Newman JJ
Mol Biol Rep; 2020 Nov; 47(11):8439-8450. PubMed ID: 33021719
[TBL] [Abstract][Full Text] [Related]
29. RUNX1 is required for oncogenic
Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
[TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias.
Lee SH; Jeong EG; Yoo NJ; Lee SH
APMIS; 2007 Dec; 115(12):1357-63. PubMed ID: 18184405
[TBL] [Abstract][Full Text] [Related]
31. How to resist Notch-targeted T-leukemia therapy: Lineage- and MYC enhancer switch.
Bayer M; Grosschedl R
Mol Cell; 2022 Mar; 82(5):884-886. PubMed ID: 35245453
[TBL] [Abstract][Full Text] [Related]
32. PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature.
Efimenko E; Davé UP; Lebedeva IV; Shen Y; Sanchez-Quintero MJ; Diolaiti D; Kung A; Lannutti BJ; Chen J; Realubit R; Niatsetskaya Z; Ten V; Karan C; Chen X; Califano A; Diacovo TG
Mol Cancer Ther; 2017 Oct; 16(10):2069-2082. PubMed ID: 28716817
[TBL] [Abstract][Full Text] [Related]
33. Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression.
Franciosa G; Diluvio G; Gaudio FD; Giuli MV; Palermo R; Grazioli P; Campese AF; Talora C; Bellavia D; D'Amati G; Besharat ZM; Nicoletti C; Siebel CW; Choy L; Rustighi A; Sal GD; Screpanti I; Checquolo S
Oncogene; 2016 Sep; 35(36):4741-51. PubMed ID: 26876201
[TBL] [Abstract][Full Text] [Related]
34. Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC.
Frank SB; Berger PL; Ljungman M; Miranti CK
J Cell Sci; 2017 Jun; 130(11):1952-1964. PubMed ID: 28446540
[TBL] [Abstract][Full Text] [Related]
35. Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.
Masiero M; Minuzzo S; Pusceddu I; Moserle L; Persano L; Agnusdei V; Tosello V; Basso G; Amadori A; Indraccolo S
Leukemia; 2011 Apr; 25(4):588-98. PubMed ID: 21263446
[TBL] [Abstract][Full Text] [Related]
36. Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress.
Melnick AF; Mullin C; Lin K; McCarter AC; Liang S; Liu YE; Wang Q; Jerome NA; Choe E; Kunnath N; Bodanapu G; Akter F; Magnuson B; Kumar S; Lombard DB; Muntean AG; Ljungman M; Sekiguchi J; Ryan RJH; Chiang MY
Blood; 2023 Dec; 142(25):2159-2174. PubMed ID: 37616559
[TBL] [Abstract][Full Text] [Related]
37. High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling.
Medyouf H; Gusscott S; Wang H; Tseng JC; Wai C; Nemirovsky O; Trumpp A; Pflumio F; Carboni J; Gottardis M; Pollak M; Kung AL; Aster JC; Holzenberger M; Weng AP
J Exp Med; 2011 Aug; 208(9):1809-22. PubMed ID: 21807868
[TBL] [Abstract][Full Text] [Related]
38. Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia.
Xi M; Guo S; Bayin C; Peng L; Chuffart F; Bourova-Flin E; Rousseaux S; Khochbin S; Mi JQ; Wang J
Front Med; 2022 Jun; 16(3):442-458. PubMed ID: 34669156
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
Rao SS; O'Neil J; Liberator CD; Hardwick JS; Dai X; Zhang T; Tyminski E; Yuan J; Kohl NE; Richon VM; Van der Ploeg LH; Carroll PM; Draetta GF; Look AT; Strack PR; Winter CG
Cancer Res; 2009 Apr; 69(7):3060-8. PubMed ID: 19318552
[TBL] [Abstract][Full Text] [Related]
40. A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies.
Ortega M; Bhatnagar H; Lin AP; Wang L; Aster JC; Sill H; Aguiar RC
Leukemia; 2015 Apr; 29(4):968-76. PubMed ID: 25311243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
